Animal drug compounding is a mixing or of drugs prepared by approved pharmacist to fulfill the particular patient’s requirement. These drugs are made by combination and alteration of necessary active pharmaceutical ingredients as per prescription and requirement. Drugs compounding also includes preparing a suspension from crushed tablets and adding flavors to it. Drug compounding allows only the use of FDA approved drugs, not the raw pharmaceutical ingredients. Drug compounding also allows veterinarians to treat animals with available human medical drugs. In most rare cases, when there are no approved drugs available for the treatment of a particular condition, the animal drug can be compounded from bulk drug substances which can be an appropriate treatment option. Despite several advantages of compounded drugs, these drugs are not intended to use for food-producing animals such as cattle, sheep, swine, goats, chickens, turkeys and non-ornamental fish.
Request TOC (desk of content material), Figures and Tables of the report: http://www.persistencemarketresearch.com/toc/12871
The growth of veterinary drug compounding market is mainly driven by the increasing number of pets and growing adoption of compounded drugs to increase animal compliance with flavoring alternatives and route of administration. Currently, many drugs are approved for animal treatment. However, these are still many different species with different rare diseases conditions for which there are no FDA-approved drugs available. To overcome this issue many approved human drugs are used for the treatment of the animal with the help of drug compounding, for example, several approved chemotherapeutic drugs are used to treat cancer in dogs and cats. Moreover, the emergence of veterinary specialties such as oncology, cardiology, and neurology, and the growth of veterinary referral centers is expected to drive the need for compounded medications. The growing trend of pet adoption is expected to boost the veterinary drug compounding market. In Japan, the companion dog population has increased to approximately 12.5 million and cats have increased up to 11.6 million. Similarly, in Australia, the companion dog population has increased to 3.75 million, cats up to 2.43 million, and other animals such as birds, rodents, and fish has increased to 32.9 million other animals.
Based on product type, oral products are the most used product for the different animal due to the easy of drug administration, drug compounding process, and large scale adoption across the globe. Based on the end user segment, veterinary compounded drugs are widely used for companion animals owing to the growing animal sports industry and pet industry, and similarly, growing expenditure on pet animal healthcare is expected to drive the growth for the veterinary drugs compounding market during the forecast period.
Based on geographic region, veterinary drugs compounding market is segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and Middle East & Africa. North America holds the largest revenue share in the veterinary drugs compounding market followed by Europe owing to well-established animal healthcare market and growing number of veterinary practitioners etc. Asia-Pacific is expected to grow at the fastest CAGR owing to the growing trend of pet animals especially in China and India. Moreover, increasing the focus of pet owners towards the animal health and safety have boosted the growth for veterinary drugs compounding market.
View Sample Report @ http://www.persistencemarketresearch.com/samples/12871
Some of the key players in veterinary drug compounding market are Sanofi-Aventis, Novartis, Fagron, Pfizer Inc., Essential Pharmacy Compounding, Triangle Compounding Pharmacies, and Lorraine’s Pharmacy among others.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, product types, end users, and distribution channel.
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Persistence Market Research Pvt. Ltd
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353